Sessions by Day

Saturday, 5 December 2015

Plenary sessions

Time

Title

Room

09:00 – 10:00

Tackling tuberculosis in key affected populations (cs, tb)

Auditorium I

Symposia

Time

Title

Room

10:30 – 12:00

27. Building on emerging knowledge to develop novel regimens for paediatric drug-resistant TB (clh, mdr-tb, tb)

Ballroom West-CTICC

10:30 – 12:00

28. End TB, end MDR-TB (tb, mdr-tb)

MR 2.41-2.43

10:30 – 12:00

29. Pneumonia in children and adults beyond 2015 (clh, lh, ncds)

MR 2.44-2.46

10:30 – 12:00

30. Eliminating the burden of TB in indigenous populations (tb)

MR 2.61-2.63

10:30 – 12:00

31. High-burden, neglected patients: addressing the intersection of tuberculosis and mental disorders (tb, ncds)

MR 2.64-2.66

10:30 – 12:00

32. Does MPOWER empower women? (tc)

Ballroom East-Westin

10:30 – 12:00

33. Modelling to support TB control policy in the era of the End TB Strategy (tb)

Ballroom West-Westin

13:30 – 15:00

34. MDR-TB: a complex disease requiring a comprehensive health system response | en français (mdr-tb, tb)

Ballroom East-CTICC

13:30 – 15:00

35. Controversies and critical issues in clinical trial design for TB (tb, res)

Auditorium II

13:30 – 15:00

36. Innovations to improve the TB-HIV patient experience: from diagnosis to treatment (hiv, tb)

Ballroom West-CTICC

13:30 – 15:00

63. Zoonotic TB session II: What do humans, baboons and livestock have in common? (zoo)

MR 1.41-1.42

13:30 – 15:00

37. Inhaled therapies for tuberculosis (tb)

MR 2.41-2.43

13:30 – 15:00

38. Affordable solutions to indoor air pollution for one-third of the world's population (lh)

MR 2.61-2.63

13:30 – 15:00

39. Taking stock of TB epidemiological assessments: experience, lessons learned and the way forward (tb)

MR 2.64-2.66

13:30 – 15:00

40. Reinforcing research for TB elimination at the country level: experiences from path-finding countries (tb, res)

Ballroom West-Westin

15:30 – 17:00

41. The Union/CDC Late-breaker Session on TB | en français (tb, res)

Auditorium I

15:30 – 17:00

42. TB research and communities: ethical and practical considerations | en français (tb, res, cs)

Ballroom East-CTICC

15:30 – 17:00

43. Country experiences: enablers for community-based multidrug-resistant tuberculosis management programmes (mdr-tb, cs, tb)

Roof Terrace

15:30 – 17:00

44. Achieving quality Xpert MTB/RIF use for rapid case detection (tb)

Auditorium II

15:30 – 17:00

45. Finding better treatments sooner: innovations in clinical trials for new regimens beyond 2015 (res, tb)

Ballroom West-CTICC

15:30 – 17:00

46. Strengthening community systems: building the evidence for impact (tb, cs)

MR 2.41-2.43

15:30 – 17:00

47. Getting patients treated for latent TB infection (LTBI) as TB prevention (tb)

MR 2.44-2.46

15:30 – 17:00

48. Beyond accelerated drug development: building successful partnerships and platforms as a critical path to TB drug regimens and PreDiCT-TB (tb, res)

MR 2.61-2.63

15:30 – 17:00

49. Sanatoria: back to the future? (tb)

MR 2.64-2.66

15:30 – 17:00

50. Smokeless tobacco: a silent killer (tc)

Ballroom East-Westin

15:30 – 17:00

51. e/m-Health as a transformational tool in TB control in high-burden countries (tb)

Ballroom West-Westin

15:30 – 17:00

52. Developing a rights-based approach to prevention and treatment of tuberculosis (cs, tb)

Da Gama/Diaz-Westin

E-poster sessions

Time

Title

Room

12:30 – 13:30

06. Preventing infection and transmission of TB in health facilities and the community (tb)

Poster Area

12:30 – 13:30

07. The rainbow session: treatment vaccination, surveillance or tuberculosis and everything in between (tb)

Poster Area

12:30 – 13:30

08. High-definition insights into drug-resistant tuberculosis (mdr-tb, tb)

Poster Area

12:30 – 13:30

09. Behind bars: TB in correctional settings - II (tb)

Poster Area

12:30 – 13:30

10. The neglected cousins: trends and treatment of non-tuberculous mycobacteria (tb, hiv)

Poster Area

Poster discussion sessions

Time

Title

Room

12:30 – 13:30

26. TART: TB risk and impact of ART (hiv, tb)

Poster Area

12:30 – 13:30

27. Drug-resistant TB: outcomes (mdr-tb, tb)

Poster Area

12:30 – 13:30

28. Drug-resistant TB: epidemiology and transmission (mdr-tb, tb)

Poster Area

12:30 – 13:30

29. LTBI testing, perceptions and epidemiology (tb)

Poster Area

12:30 – 13:30

30. Collaborative services for TB and diabetes (tb)

Poster Area

12:30 – 13:30

31. Spatial epidemiology of tuberculosis (tb)

Poster Area

12:30 – 13:30

32. The game of numbers: prevalence and incidence of tuberculosis (tb)

Poster Area

12:30 – 13:30

33. Molecules, polymorphisms and resistance to TB (tb)

Poster Area

12:30 – 13:30

34. Thinking broadly to advance the END TB Strategy (tb)

Poster Area

12:30 – 13:30

35. Financial impact of TB (tb)

Poster Area

12:30 – 13:30

36. Molecular diagnostics: pitfalls and improvements (tb)

Poster Area

12:30 – 13:30

37. Rapid diagnosis the world over (tb)

Poster Area

12:30 – 13:30

38. Phenotypes and genotypes: deciphering resistance development (mdr-tb, tb)

Poster Area

12:30 – 13:30

39. Tuberculosis drug resistance and susceptibility testing in a nutshell (mdr-tb, tb)

Poster Area

12:30 – 13:30

40. From safety to supply-chain: let's talk lab management (tb)

Poster Area

12:30 – 13:30

41. Stepping up patient access and support (cs, naps, tb)

Poster Area

12:30 – 13:30

42. Inside the belly of the beast: TB in correctional settings (tb)

Poster Area

12:30 – 13:30

43. The urban-rural divide: different places, similar issues (tb)

Poster Area

12:30 – 13:30

44. Paediatric TB: MDR (clh, mdr-tb)

Poster Area

12:30 – 13:30

45. Paediatric TB: training, BCG and pharmacokinetics (clh)

Poster Area

12:30 – 13:30

46. Harmful effects of second-hand smoke (tc)

Poster Area

12:30 – 13:30

47. Monitoring the tobacco industry: promotion and advertisements (tc)

Poster Area

12:30 – 13:30

48. Enforcement of smoke-free legislation (tc)

Poster Area

12:30 – 13:30

49. Strategies to improve TB-HIV screening and service integration (hiv, tb)

Poster Area

Oral abstract sessions

Time

Title

Room

10:30 – 12:00

11. Improving TB treatment outcomes | en français (tb)

Auditorium I

10:30 – 12:00

12. MDR-TB: impacts of detection and early treatment | en français (mdr-tb, tb)

Ballroom East-CTICC

10:30 – 12:00

13. LTBI in high- and low-burden settings (tb)

Roof Terrace

10:30 – 12:00

14. From specimens to outcome: new information for molecular diagnosis (tb)

Auditorium I

10:30 – 12:00

15. When waves trump paper: the triumph of e-technology (tb)

Da Gama/Diaz-Westin

13:30 – 15:00

16. From bench to treatment | en français (mdr-tb, tb)

Auditorium I

13:30 – 15:00

17. TB & NCD co-morbidity (tb)

Roof Terrace

13:30 – 15:00

18. TB in children: diagnosis prevention and best practice (clh, tb)

MR 2.44 - 2.46

13:30 – 15:00

19. Tobacco: economics and illicit trade (tc)

Ballroom East-Westin

13:30 – 15:00

20. IAP, pneumonia, asthma and chronic lung disease (lh, ncds)

Da Gama/Diaz-Westin

Meet-the-expert sessions

Time

Title

Room

08:00 – 08:50

1. The use of our first line drugs in children – Peter Donald (South Africa) (clh)

MR 2.41-2.43

08:00 – 08:50

2.1 From the recent literature on HIV – Stephen Lawn (UK) (hiv, tb)

MR 2.44–2.46

08:00 – 08:50

3. Vaccine development - Mark Hatherill (South Africa) (hiv, clh, tb)

MR 2.61-2.63

08:00 – 08:50

4. Tobacco industry interference with tobacco control – Lekhan Ayo-Yusuf (South Africa) (tc)

MR 2.64–2.66

08:00 – 08:50

5. Nurse-initiated MDR-TB treatment - Khaya Mlandu (South Africa) (mdr-tb, naps)

Da Gama/Diaz - Westin

Side-meetings

Time

Title

Room

10:00 – 11:30

Friends of Pakistan - Closed Meeting (tb)

MR 1.41/1.42

Union meetings

Time

Title

Room

07:45 – 09:00

Union Scientific Section meeting: HIV (hiv)

Auditorium II

12:00 – 13:30

Union Scientific Section meeting: Tobacco control (tc)

Sir F Drake – Westin

12:15 – 13:15

Union Region meeting: Asia Pacific

MR 2.44–2.46

12:15 – 13:15

Union Region meeting: Middle East

MR 2.64–2.66

12:15 – 13:15

Union Region meeting: North America

MR 2.61–2.63

14:00 – 15:30

Inter-regional Meeting

MR 1.43, MR 1.44

17:15 – 18:15

GENERAL ASSEMBLY 2015

Auditorium II

18:30 – 20:30

Scientific Programme Committee (CCSA Sub-Group 2)

Boardroom

Sessions by Day

Topics Legend